1st Quarter - Report
THE MCMANUS GROUP for ALLERGAN INC
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to select agents H.R. 1038, "Access to Life-Saving Medicine Act," all provisions. H.R. 5629, "Pathway for Biosimilars Act."
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Taxation/Internal Revenue Code TAX
Extension of the research and development tax credit. Support for H.R. 2138, "Investment in America Act of 2007."
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Medicare/Medicaid MMM
Clarification of scope of Medicaid rebates for physician-administered drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.